Mode
Text Size
Log in / Sign up
N/A Completed N=40 Randomized Double-blind Treatment

Muscle Regrowth During Physical Rehabilitation and Amino Acid Supplementation

Source: ClinicalTrials.gov NCT00760383 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Dec 2014
Primary outcomePrimary: Stair Time up — 7; 8 seconds

Summary

The general hypothesis is that in older adults muscle regrowth after an acute musculoskeletal stress will be positively influenced by traditional physical rehabilitation, and further enhanced by nutritional supplementation. Using state-of-the-art stable isotope methodologies for the study of muscle metabolism and methodologies for the measurement of cell signaling, we will test the following specific hypotheses: 1) Total knee arthroplasty (TKA) induces an acute net protein catabolism mainly by reducing muscle protein synthesis; 2) TKA induced catabolism is attenuated by the ingestion of essential amino acids (EAA); 3) EAA supplementation in combination with physical therapy (PT) will stimulate muscle protein synthesis and mTOR signaling to a greater extent than PT with Placebo; and 4) EAA supplementation during TKA PT rehabilitation will improve muscle strength, muscle volume and functional outcomes to a greater extent than PT with Placebo. Public Benefit: This research will focus rehabilitation efforts on specific and currently unresolved mechanisms responsible for muscle loss following total knee replacement in older adults. While knee pain due to bone arthritis is often alleviated after knee replacement, complete return of physical function and independence is difficult to achieve. This research will help to restore physical function and independence in the rapidly growing population of older adults with knee arthritis.

Outcome Measures

OutcomeResultp-value
PRIMARY
Stair Time up
7; 8
PRIMARY
Quadriceps Muscle Strength
65; 81
SECONDARY
Mid-thigh Muscle Volume
109; 108

Eligibility Criteria

Inclusion Criteria

  • Total Knee Arthroplasty surgical candidate

Exclusion Criteria

  • Overt muscle disease
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00760383). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search